![](/img/cover-not-exists.png)
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
Knopp, R. H., d'Emden, M., Smilde, J. G., Pocock, S. J.Volume:
29
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc05-2415
Date:
July, 2006
File:
PDF, 274 KB
english, 2006